• NEWS

    NEWS

    THE LATEST NEWS, DEVELOPMENTS AND ANNOUNCEMENTS AS THEY HAPPEN

    more
  • EVENTS

    EVENTS

    CONFERENCES, TRADE SHOWS, LIVE WEBCASTS, NEW LAUNCHES, SEMINARS AND TRAINING EVENTS

    more
  • COMPANIES

    COMPANIES

    PARTNERS, SOLUTIONS & SERVICE PROVIDERS, SUPPLIERS AND INDUSTRY ORGANIZATIONS

    more
  • RESOURCES

    RESOURCES

    WHITEPAPERS, MARKET REPORTS, RESEARCH, ON-DEMAND WEBINARS, VIDEOS AND INFOGRAPHICS

    more

NEWS

   

EVENTS

Conferences

2nd International Conference On Advances In Biotechnology

2ND INTERNATIONAL CONFERENCE ON ADVANCES IN BIOTECHNOLOGY

July 23-25, 2018
Biotechnology is the use of living systems and organisms to develop or modify products or processes for specific use. Biotechnology encompasses a wide range of procedures for modifying living organisms according to human purposes, going back to domestication of animals, cultivation of the plants, an...

Pre-approval Access Programs Summit

PRE-APPROVAL ACCESS PROGRAMS SUMMIT

July 23-25, 2018
Join us at the second annual Pre-approval Access Programs Summit to reconvene with major topic influencers and be a part of the plan the future of Pre-Approval. Pharmaceutical and biotech executives, patient advocates, regulators and academia combine forces to create an all-encompassing program spot...

11th International Conference on Virology and Microbiology

11TH INTERNATIONAL CONFERENCE ON VIROLOGY AND MICROBIOLOGY

July 27-28, 2018
Virology Congress 2018 will focus on the latest and exciting innovations in all areas of Virology and Microbiology research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. Infectious Diseases are disorders caused by orga...

ALZHEIMER

ALZHEIMER'S DISEASE INTERNATIONAL'S 33RD CONFERENCE

July 26-29, 2018
Alzheimer’s Disease International (ADI) is proud that its international conference is the longest running and one of the largest international conferences on dementia, attracting over 1,000 delegates from over 100 countries. Featuring a range of international keynote speakers and a high standa...

ICBB 2018 : 20th International Conference on Biotechnology and Biochemistry

ICBB 2018 : 20TH INTERNATIONAL CONFERENCE ON BIOTECHNOLOGY AND BIOCHEMISTRY

July 19-20, 2018
The ICBB 2018: 20th International Conference on Biotechnology and Biochemistry aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Biotechnology and Biochemistry. It also provides a premi...

ICPMB 2018 : 20th International Conference on Pharmacy and Molecular Biotechnology

ICPMB 2018 : 20TH INTERNATIONAL CONFERENCE ON PHARMACY AND MOLECULAR BIOTECHNOLOGY

July 19-20, 2018
The ICPMB 2018: 20th International Conference on Pharmacy and Molecular Biotechnology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacy and Molecular Biotechnology. It also pro...

8th Annual Conference on Clinical Research & Biomarkers

8TH ANNUAL CONFERENCE ON CLINICAL RESEARCH & BIOMARKERS

July 19-20, 2018
EuroSciCon extends its warm welcome to all its participants to Clinical Research & Biomarkers 2018 scheduled on July 19-20, 2018 at Prague, Czech Republic with a theme “The Current Aspects and The Future of Clinical Research and Biomarkers". EuroSciCon organizes Global Events with Con...

28th International Conference on Cancer Research and Anticancer Therapies

28TH INTERNATIONAL CONFERENCE ON CANCER RESEARCH AND ANTICANCER THERAPIES

September 17-18, 2018
Cancer Congress 2018 is a trending event which brings together efficient international academic scientists, young researchers and students making the congress a perfect platform to share experiences, gain and evaluate emerging technologies in Cancer Treatment and Radiology across the globe. Initiati...

 

Webinars

JUL 26, 2018 | 9:30 AM
LABORATORY QUALITY PRACTICES FOR GLOBAL REGULATORY CMC ANALYTICAL STUDIES FOR BIOTECHNOLOGY/BIOSIMILAR PRODUCTS: R&D TO GMP
During the course of product development, and in the support of commercialized products, there are numerous biotech CMC studies conducted in non-GLP/non-GMP analytical laboratories (“R&D” labs).  While it is true that these R&D labs are not required to follow GxP r...
JUL 26, 2018 | 11:00 AM
FRAGILE X ASSAYS ON THE SEQSTUDIO GENETIC ANALYZER
This is the sixth topic in the webinar series on ‘Sanger Sequencing & Fragment Analysis made easy’. In this 30 minute talk, Dr. William G. Kearns, Founder, and Director at AdvaGenix will focus on Fragile-X assays and the use of the Applied Biosystems SeqStudio Genetic Analy...
JUL 31, 2018 | 10.00 AM
BUILDING A FASTER, MORE FLEXIBLE BIOLOGIC DEVELOPMENT PROCESS FOR TARGETED THERAPIES
With the dramatic rise in the number of precision medicines and orphan drug designations in development many of which are biologics many companies are racing furiously to get these precious and expensive molecules to the clinic as quickly as possible. Speed, small batch sizes, material los...
AUG 07, 2018 | 11:00 am
USING REFERENCE STANDARDS TO VALIDATE YOUR NGS ONCOLOGY WORKFLOW
We are currently at an exciting precipice in clinical oncology management, where an increased rate of biomarker identification is driving the development of new targeted therapies, coupled with advances in sequencing technology capability. In the latest version release of COSMIC (v85) ther...
AUG 08, 2018 | 1:00 PM
MOLECULAR ELUCIDATION AND ENGINEERING OF STEM CELL FATE DECISIONS
As the field progressively learns more about the mechanisms that control stem cell behavior – in particular their two hallmark properties of self-renewal and differentiation – deeper insights are gained into their potential roles and applications in organismal development, adul...
AUG 09, 2018 | 01:00 PM
FDA REGULATION OF HUMAN CELLS, TISSUES AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/PS)
Stem cells have the ability to differentiate into numerous cells upon various stimulations. This has led to their wide utilization across several therapeutic areas of medicine, including high-risk diseases. Of course, significant scientific breakthroughs in the use of stem cells to prevent...

PLANTS WITH SUPERPOWERS (GMO) WEBINAR
Sponsored
We’ve all seen non-GMO labels in the grocery store. What does GMO mean and why should we care? In this webinar, Biology Fortified will show how biotechnology can be used to give plants superpowers. We will discuss plant breeding methods, current and future GMO traits, GMO safety, and...
DNA METHYLATION CHANGES DURING CELL DIFFERENTIATION WEBINAR
Sponsored
Listen in as Dr Ballestar discusses an overall perspective on the connections between DNA methylation and other epigenetic marks, as well as the interplay with transcription factors.
EARLY DRUG DISCOVERY EXPERIENCES FROM A SMALL BIOTECH.
The remit of our company, a charity and small biotech, is to help accelerate the process of target validation and generating tool compounds for enabling further exploration of new targets (as proposed by our various academic collaborators in the UK and across the world). Essentially this m...
THE POTENTIAL OF ENGINEERED HUMAN LIVER CO-CULTURES IN PHENOTYPIC DRUG DISCOVERY FOR LIVER DISEASES
The diverse functions of the liver (i.e. albumin synthesis, glucose and fatty acid metabolism, drug metabolism) can be severely compromised by several diseases. In particular, drug-induced liver injury is a leading cause of drug attrition; hepatitis B virus chronically infects the livers o...
COMBINING TRANSPORTER DATA WITH QUANTITATIVE SYSTEMS TOXICOLOGY MODELING (DILISYM) TO IMPACT DECISIONS IN DRUG DEVELOPMENT
A quantitative systems toxicology (QST) model of drug-induced liver injury (DILI) has been developed through the DILI-sim Initiative over the past 7 years to assist in the safety characterization of compounds in clinical development.  The emerging platform, DILIsym®, is capable of...
THE UTILITY OF MICROSCALE HUMAN LIVER CO-CULTURES FOR INVESTIGATING DRUG TOXICITY OUTCOMES
Drug-induced liver injury (DILI) remains a leading cause of acute liver failures and the attrition of pharmaceuticals in both preclinical and clinical settings. Due to species-specific differences in drug metabolism pathways, animal models do not always fully predict human DILI. Thus, ther...
ENGINEERING MICROPATTERNED CO-CULTURES FOR DRUG DEVELOPMENT
Due to significant differences across species in liver pathways, models of the human liver are used to screen for potential efficacy and/or toxicity of candidate compounds. Such models serve to complement and reduce the number of animals used in studies required by regulatory agencies. How...

RESOURCES

The pharmaceutical and medical industry suffers huge pain, high cost and poor results from conventional biological indicators. This new science of using Enzyme Indicators for measuring decontamination...

The combination of laboratory automation and on-line analytic shows clear advantages and increases lab efficiency significantly, especially when it comes to time-consuming tasks, without neglecting th...

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with d...

No other problem in cell culturing is as universal as microbial contamination. In order to avoidit, good sterile techniques and thorough culture handling are essential. Beyond that, the CO2 incubator ...

New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient methods are requ...

During the cultivation of animal cells the monitoring of nutrients and metabolites has an important role for the controlling strategy of the cell culture. The measurement of glucose and lactate is one...

Design of experiments (DoE) is one of the most important techniques for systematic planning, execution and statistical evaluation of experiments. Although a DoE investigation is executable in one bior...

The development of biosimilars requires extensive physicochemical characterization of biosimilar candidate molecules which should match the quality profile of the reference molecule (originator). Here...

The presented data demonstrates that chemical denaturation is a feasible approach to predict the colloidal long-term stability of biologicals. Moreover, changes in G in dependence of the protein con...